21 State Attorneys General Urge Biden Administration to Ban Flavored Tobacco Products

Regulations by 2FIRSTS.ai
Jan.17.2024
21 State Attorneys General Urge Biden Administration to Ban Flavored Tobacco Products
US Attorneys General from 21 states have urged the Biden administration to swiftly implement proposed regulations banning the sale of menthol cigarettes and flavored cigars.

According to a report by the American media outlet Riverbender on January 16th, the Attorneys General from 21 US states have submitted a letter to the Biden administration, urging them to complete the review and swiftly implement proposed regulations to ban the sale of menthol cigarettes and flavored cigars.

 

The letter emphasizes the urgent need for action to remove menthol tobacco products from the market in order to safeguard public health and address the systemic and disproportionate impact of such products on minority communities and other vulnerable groups, including young people.

 

"I urge the US Food and Drug Administration (FDA) to ban menthol cigarettes and flavored cigars, as despite a decline in overall tobacco use over the past two years, flavored tobacco products continue to attract and addict new smokers, particularly among young people and minority smokers," the letter stated.

 

In their capacity as chief legal officers of various states and territories, these attorneys general have refuted baseless claims that a proposed ban on menthol cigarettes would increase illegal trade or unjustly criminalize individuals for the purchase, possession, or use of menthol cigarettes and flavored cigars. The letter asserts that the proposed regulations by the U.S. Food and Drug Administration (FDA) aim to advance health equity and protect public health.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

ceshi1111
ceshi1111
Trusted by industry leaders and innovators, ARAC brings unmatched expertise in Modules 5 & 6, including label and claim development, comprehension testing, human factors/usability, and clinical-behavioral research such as actual use and switching studies. These studies generate the robust, real-world evidence needed to evaluate whether products are “Appropriate for the Protection of Public Health” (APPH) -- including randomized experimental longitudinal, actual use, cohort st
Oct.21
Heno Biotech Invited to Speak at PouchEX 2025 in Stockholm, Introduces Supply Chain Competency Model for the Nicotine Pouch Industry
Heno Biotech Invited to Speak at PouchEX 2025 in Stockholm, Introduces Supply Chain Competency Model for the Nicotine Pouch Industry
Heno Biotech was invited to deliver a keynote address at PouchEX Stockholm 2025, presenting a new supply chain competency model for the nicotine pouch sector. The company showcased its end-to-end capabilities—from scientific research and advanced manufacturing to global regulatory compliance—underscoring the critical role of supply chain upgrading in driving sustainable industry growth.
Nov.24
Smoore: Profit Growth Gradually Improving, Fourth Quarter Shows Promise — A 2Firsts Reader Submission
Smoore: Profit Growth Gradually Improving, Fourth Quarter Shows Promise — A 2Firsts Reader Submission
Smoore released its financial results for the third quarter of 2025.A reader submitted to 2Firsts, noting that Smoore’s declining profit margin was mainly due to the substantial upfront investment in its new heated tobacco products, the relatively low margins of vaping devices, and price reductions resulting from product iterations in the European atomization market.as product structure adjustments near completion, the company’s profit growth is expected to further rebound in the fourth quart.
Oct.13
China’s E-Cigarette Exports Reached USD 879 Million in September 2025, Down 6.08% MoM— U.S. Remains Top Market, Russia Falls Sharply
China’s E-Cigarette Exports Reached USD 879 Million in September 2025, Down 6.08% MoM— U.S. Remains Top Market, Russia Falls Sharply
In September 2025, China’s total e-cigarette exports reached USD 879 million, representing a 6.08% decline month-on-month but a 3.41% increase year-on-year.
Oct.20 by 2FIRSTS.ai
Philip Morris International Fails to Invalidate British American Tobacco Unit’s Vape Patent
Philip Morris International Fails to Invalidate British American Tobacco Unit’s Vape Patent
The European Patent Office’s Board of Appeal upheld British American Tobacco’s Nicoventures Trading Ltd. vape patent, rejecting Philip Morris International’s objections. The board ruled that the patent’s use of predefined heater activation parameters not based on user puffs was novel and valid.
Nov.10
German Federal Council calls for ban on disposable vape, government resists change
German Federal Council calls for ban on disposable vape, government resists change
Germany's Federal Council calls for ban on disposable e-cigarettes due to environmental and economic threats, sparking debate.
Oct.14 by 2FIRSTS.ai